Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02798536
Title Mesothelin-Targeted Immunotoxin LMB-100 in People With Malignant Mesothelioma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

malignant epithelial mesothelioma

malignant biphasic mesothelioma

Therapies

LMB-100

LMB-100 + Nab-paclitaxel

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.